Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trapp, J. F.
Right arrow Articles by Schwartz, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trapp, J. F.
Right arrow Articles by Schwartz, D. A.
(Chest. 1998;113:505-513.)
© 1998 American College of Chest Physicians

The Effect of Glucocorticoids on Grain Dust-Induced Airway Disease

John F. Trapp MD1; Janet L. Watt BA1; Kathy L. Frees 1; Timothy J. Quinn BS1; Matthew W. Nonnenmann 1; and David A. Schwartz MD, MPH, FCCP1

1 From the Pulmonary Diseases, Critical Care, and Occupational Medicine Division, Department of Internal Medicine, The University of Iowa College of Medicine, Iowa City

Study objectives: To determine the effect of glucocorticoids on grain dust-induced airflow obstruction and airway inflammation.

Design: Randomized controlled trial.

Setting: University hospital.

Participants: Health volunteers.

Interventions: Two randomized, placebo-controlled trials, each studying 10 healthy volunteers who were pretreated with either triamcinolone acetonide (Azmacort) oral inhaler 4 puffs twice daily (800 µg daily) for 7 consecutive days or IV hydrocortisone (3 µg/kg/min) as a 14-h continuous infusion, then subjected to a controlled inhalation exposure to corn dust extract (CDE) (endotoxin exposure dose of 3 µg/kg). A single-blind, crossover study design was performed for each trial enrolling 10 healthy, lifetime nonsmokers, with no history of lung disease or environmental exposure to grain dust.

Measurements and results: Following each inhalation exposure to CDE, spirometry was performed at regular intervals and BAL was performed at 4 h. Both treatment and placebo groups demonstrated significant decrements in spirometry and increments in BAL cellularity following CDE inhalation compared with placebo. Inhaled steroid treatment resulted in a significantly higher FEV1 only at the 2-h time point following CDE inhalation with no significant differences observed in the BAL total cell concentration or cellular differential compared with placebo. IV hydrocortisone treatment resulted in a significantly higher FEV1 and FVC between 2 and 4 h after CDE inhalation, as well as significant reductions in the BAL total cell, macrophage, and eosinophil concentrations. Interestingly, the concentration of tumor necrosis factor-agr and interleukin-8 in the BAL fluid was also decreased following treatment with IV glucocorticoids.

Conclusions: These results demonstrate that glucocorticoids, administered IV and perhaps by inhalation, have a mildly protective effect on airflow obstruction and airway inflammation induced by inhalation of grain dust.

Key Words: airway injury • asthma • glucocorticoids • grain dust

Submitted on June 25, 1997
Accepted on August 25, 1000




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
I. Rubinstein and S. G. Von Essen
Hog barn dust extract increases macromolecular efflux from the hamster cheek pouch
J Appl Physiol, July 1, 2006; 101(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. N. KLINE, J. D. COWDEN, G. W. HUNNINGHAKE, B. C. SCHUTTE, J. L. WATT, C. L. WOHLFORD-LENANE, L. S. POWERS, M. P. JONES, and D. A. SCHWARTZ
Variable Airway Responsiveness to Inhaled Lipopolysaccharide
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 297 - 303.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. A. Schwartz, C. L. Wohlford-Lenane, T. J. Quinn, and A. M. Krieg
Bacterial DNA or Oligonucleotides Containing Unmethylated CpG Motifs Can Minimize Lipopolysaccharide-Induced Inflammation in the Lower Respiratory Tract Through an IL-12-Dependent Pathway
J. Immunol., July 1, 1999; 163(1): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. R. Akhter, H. Ikezaki, X.-P. Gao, and I. Rubinstein
Dexamethasone attenuates grain sorghum dust extract-induced increase in macromolecular efflux in vivo
J Appl Physiol, May 1, 1999; 86(5): 1603 - 1609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.